NCT01372865

A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)

A Phase III, Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis With Eurofarma Mometasone or Reference Mometasone.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 364 (actual)
• Sponsor: Eurofarma Laboratorios S.A. · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The primary objective will be to compare the impact of the study formulations on alergic rhinitis carriers.

Conditions

• Mild to Moderate Persistent Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Mometasone furoate
DRUG	Mometasone furoate

Timeline

• Start date: 2012-06-01
• Primary completion: 2013-02-01
• Completion: 2013-03-01
• First posted: 2011-06-14
• Last updated: 2017-09-18

Locations

1 site across 1 country: Brazil